(Q35575024)

English

Epidermal Growth Factor Receptor Inhibitors, Gefitinib and Erlotinib (Tarceva™, OSI-774), in the Treatment of Bronchioloalveolar Carcinoma

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

Epidermal growth factor receptor inhibitors, gefitinib and erlotinib (Tarceva , OSI-774), in the treatment of bronchioloalveolar carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Epidermal Growth Factor Receptor Inhibitors, Gefitinib and Erlotinib (Tarceva™, OSI-774), in the Treatment of Bronchioloalveolar Carcinoma (English)

1 reference

10.1016/S1525-7304(11)70324-2

https://api.crossref.org/works/10.1016/S1525-7304(11)70324-2

28 March 2024

1 reference

10.1016/S1525-7304(11)70324-2

https://api.crossref.org/works/10.1016/S1525-7304(11)70324-2

28 March 2024

author name string

Heather DeGrendele

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S1525730411703242?httpAccept=text/xml

1 reference

10.1016/S1525-7304(11)70324-2

https://api.crossref.org/works/10.1016/S1525-7304(11)70324-2

28 March 2024

https://api.elsevier.com/content/article/PII:S1525730411703242?httpAccept=text/plain

1 reference

10.1016/S1525-7304(11)70324-2

https://api.crossref.org/works/10.1016/S1525-7304(11)70324-2

28 March 2024

Clinical Lung Cancer

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

83-85

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

The changing pattern of lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchioloalveolar carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchoalveolar carcinoma: factors affecting survival

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrence and survival following resection of bronchioloalveolar carcinoma of the lung--The Lung Cancer Study Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alveolar cell carcinoma of the lung: a retrospective analysis of 205 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel (taxotere) in the treatment of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchoalveolar cell carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970324-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1525-7304(11)70324-2

0 references

release_37gslcq4dfasdmzlhoxtkvy4ei

1 reference

https://api.fatcat.wiki/v0/release/37gslcq4dfasdmzlhoxtkvy4ei

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35575024&oldid=2112944075"